Bristol Myers Squibb Co (BMY) Stock Price & Analysis
Bristol Myers Squibb Co (BMY) fell 1.86% to USD 66.82 as of September 8, 2026 at 02:53 UTC, according to Nexqual real-time market data.
BMY last closed at USD 66.82; the session ranged USD 66.58–67.72 on volume of 4,585,275 shares. Market capitalization is —, with a 52-week range of USD 42.52–68.64 (NYQ). Source: Nexqual, September 8, 2026 at 02:53 UTC.
Key Statistics (as of September 8, 2026 at 02:53 UTC)
| Price | USD 66.82 |
|---|---|
| Change | ▼ 1.86% (down) |
| Previous Close | USD 66.82 |
| Open | USD 66.82 |
| Day Range | USD 66.58 – 67.72 |
| 52-Week Range | USD 42.52 – 68.64 |
| Volume | 4,585,275 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BMY)
Nexqual's technical model rates BMY "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 02:53 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.66 (neutral) |
| vs SMA50 | Above (USD 62.9) |
| MACD | 1.26 (positive) |
From Bristol Myers Squibb Co's Latest SEC 10-K Filing (filed 2026-02-11)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MRK | Merck & Company, Inc. | USD 150.33 | ▼ 0.86% |
| ABT | Abbott Laboratories | USD 108.33 | ▼ 1.94% |
| LLY | Eli Lilly and Company | USD 1,149.36 | ▼ 0.92% |
| ABBV | AbbVie Inc. | USD 256.46 | ▼ 2.01% |
| AMGN | Amgen Inc. | USD 437.23 | ▼ 1.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:53 UTC. This page is informational and not investment advice.